Effect of Methylprednisolone on Capillary Permeability at Surgery under Extracorporeal Circulation
https://doi.org/10.15360/1813-9779-2011-2-39
Abstract
Objective: to evaluate the effect of methylprednisolone on capillary leak syndrome at surgery under normothermic cardiopulmonary bypass. Subjects and methods. Twenty-one patients who received intravenous methylprednisolone in a dose of 20 mg/kg body weight after anesthesia induction (a study group) and 21 patients who were not given this agent (a control group) were examined. The investigators estimated the levels of creatinine, albumin, cystatin C, sE-selectin, endothe-lin-1, and glucose in blood, creatinine in urine, microalbuminuria, and blood gas composition and assessed perioperative outcomes. Results. There were statistically significant differences between both groups in microalbuminuria level and albumin/creatinine ratio. At the study stages, there were increases in inotropic support needs, blood venous shunt ratio, and the levels of glucose, endothelin-1, sE-selectin, interleukin-10, and cystatin C and decreases in glomerular filtration rate, PaO2/PAO2 and PaO2/FiO2, and IL-6 level in the methylprednisolone group as compared with the controls. Conclusion. The use of methylprednisolone was not ascertained to reduce the manifestations of capillary leak syndrome. The pulse-dose administration of glucocorticosteroids contributed to the worsening of the signs of endothelial dysfunction (such as an elevated endothelin and sE-selectin levels in the study steps) and negatively affected the recovery of pulmonary and renal functions after cardiopulmonary bypass. Key words: glucocorticosteroids, cardiopulmonary bypass, capillary leak syndrome, endothelial dysfunction.
References
1. Hirleman E., Larson D. F.
2. Toraman F., Evrenkaya S., Yuce M. et al.Highly positive intraoperative fluid balance during cardiac surgery is associated with adverse outcome. Perfusion 2004; 19 (2): 85—91.
3. Moses M. L., Camishion R. C., Tokunaga K. et al.Effect of corticosteroid on the acidosis of prolonged cardiopulmonary bypass. J. Surg. Res. 1966; 6 (8): 354—360.
4. Thompson M. A., Broadbent M. P.Methylprednisolone prior to car-diopulmonary bypass. Anaesthesia 1980; 35 (4): 345—353.
5. Whitlock R. P., Chan S., Devereaux P. J. et al.Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur. Heart J. 2008; 29 (21): 2592—2600.
6. Dharnidharka V. R., Kwon C., Stevens G.Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 2002; 40 (2): 221—22
7. Хенсли Ф. А.-мл., Мартин Д. Е., Гревли Г. П.Практическая кардио-анестезиология. 3-е изд. М.: МИА; 2008.
8. Барбараш Л. С., Григорьев Е. В., Плотников Г. П. и соавт.Полиорганная недостаточность после кардиохирургических вмешательств. Общая реаниматология 2010; VI (5): 31—34.
9. Tassani P., Richter J. A., Barankay A. et al.Does high-dose methylpred-nisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures? J. Cardiothorac. Vasc. Anesth. 1999; 13 (2): 165—172.
10. Toft P., Christiansen K., Tonnensen E. et al.Effect of methylprednisolone on the oxidative burst activity, adhesion molecules and clinical outcome after open heart surgery. Scand. Cardiovasc. J. 1997; 31 (5): 283—288.
11. von Spiegel T., Gianarris S., Wietasch G. J. et al.Effects of dexametha-sone on intravascular and extravascular fluid balance in patients undergoing coronary bypass surgery with cardiopulmonary bypass. Anesthesiology 2002; 96 (4): 827—834.
12. Jensen J. S., Borch-Johnsen K., Jensen G., Feldt-Rasmussen B.Microalbuminuria reflects a generalized transvascular albumin leak-iness in clinically health subjects. Clin. Sci. (Lond.) 1995; 88 (6): 629—633.
13. Brudney C. S., Gosling P., Manji M.Pulmonary and renal function following cardiopulmonary bypass is associated with systemic capillary leak. J. Cardiothorac. Vasc. Anesth. 2005; 19 (2): 188—192.
14. Chaney M. A.Corticosteroids and cardiopulmonary bypass. A review of clinical investigations. Chest 2002; 121 (3): 921—931.
15. Yasser M. A., Elmistekawy E., El-Serogy H.Effects of dexamethasone on pulmonary and renal functions in patients undergoing CABG with car
16. diopulmonary bypass. Semin. Cardiothorac. Vasc. Anesth. 2009; 13 (4): 231—237.
17. Galteau M. M., Guyon M., Gueguen R., Siest G.Determination of serum cystatin C: biological variation and reference values. Clin. Chem. Lab. Med. 2001; 39 (9): 850—857.
18. Apostolakis E. E., Koletsis E. N., Baikoussis N. G. et al.Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. J. Cardiothorac. Surg. 2010; 5 (1): 1—9.
19. Akaza I., Yoshimoto T., Tsuchiya K., Hirata Y.Endothelial dysfunction associated with hypercortisolism is reversible in Cushing’s syndrome. Endocr. J. 2010; 57 (3): 245—252.
20. Tabrizchi R.Corticosteroids and endothelial dysfunction. Vasc. Health Risk Manag. 2005; 1 (4): 261—262.
Review
For citations:
Kalinichenko A.P., Lomivorotov V.V., Knyazkova L.G., Kornilov I.A. Effect of Methylprednisolone on Capillary Permeability at Surgery under Extracorporeal Circulation . General Reanimatology. 2011;7(2):39. (In Russ.) https://doi.org/10.15360/1813-9779-2011-2-39
Views:
1209
Email this article 